Exchange: NASDAQ·Updated 07:37 PM EDT

CELU News

News
all
press releases
Why Is Celularity Stock Gaining Thursday?
Celularity (CELU) stock surged 131% following a $300M U.S. manufacturing collaboration with MuseCell Innovations in New Jersey.read more...
Benzinga
More News
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regular session. The company's market cap stands at $25.0 million. Propanc Biopharma (NASDAQ:PPCB) stock increased byread more...
Benzinga
Mega Movers
The market is getting a fresh reminder that the biggest opportunities are increasingly being built around AI, cybersecurity, advanced medicine and the infrastructure required to commercialize them. Propanc Biopharma (NASDAQ:PPCB), Celularity (NASDAQ:CELU), NeOnc Technologies (NASDAQ:NTHI), Salesforce (NYSE:CRM), CrowdStrike (NASDAQ:CRWD), and Okta (NASDAQ:OKTA).
24-7 Market News
Celularity’s $300M Manufacturing Opp Could Be a Bigger Deal Than the Headline Suggests
Celularity (NASDAQ:CELU) may have just added a potentially significant new dimension to its cellular-medicine story: manufacturing revenue from a third-party regenerative-medicine platform.
24-7 Market News
Celularity and MuseCell Innovations Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell Platform
Celularity Inc. (Nasdaq: CELU) (Celularity), a longevity-focused regenerative and cellular medicine company, and MuseCell Innovations Pte. Ltd. (MCI), the owner of the Dezawa MuseCell platform, today announced an additional U.S.-based manufacturing collaboration under which Celularity will...
Business Wire
Celularity (NASDAQ:CELU) Trading 0.4% Higher - Should You Buy?
Celularity (NASDAQ:CELU) Stock Price Up 0.4% - Here's Why...
MarketBeat

Advertisement|Remove ads.